Short answer
DELCATH SYSTEMS, INC. (DCTH) filed its Q3 2026 10-Q quarterly report on Nov 9, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $35M (up 70.7% year over year) with net income of $7M.
Q3 2026 key financials · XBRL
- Revenue
- $35M
- +70.7% YoY · +20.5% QoQ
- Net income
- $7M
- +737.6% YoY · +160.6% QoQ
- Operating margin
- 20.3%
- Gross margin
- 88.8%
- EPS (diluted)
- $0.17
- +466.7% YoY · +142.9% QoQ
Source: XBRL data from the DELCATH SYSTEMS, INC. (DCTH) Q3 2026 10-Q on SEC EDGAR. USD.
DELCATH SYSTEMS, INC. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $35.1M, up $14.5M YoY from $20.6M, driven by HEPZATO commercial expansion
- Operating margin 20.3% vs negative 1.9% YoY, operating income $7.1M vs $(0.4)M
- Best performer HEPZATO KIT: $32.7M revenue vs $19.3M, CHEMOSAT $2.4M vs $1.3M
- Operating cash flow $14.7M vs $14.3M YoY, cash and equivalents $55.5M plus investments $48.8M
- Outlook: liquidity expected to fund operations at least 12 months, Phase 2 trial expenses expected to increase
Risk Factors
- No material changes from the Annual Report, with business, financial condition, and results of operations exposed to disclosed risks
- Unknown or currently immaterial risks could significantly impair operations, financial condition, or results
- Common-stock market price could decline, potentially causing investors to lose all or part of their investment
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other DELCATH SYSTEMS, INC. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.